Akoya (AKYA) Misses Q2 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
Go back to Akoya (AKYA) Misses Q2 EPS by 10c
August 8, 2022 4:05 PM EDT
Q2 2022 revenue $17.9 million, 37% y/y growthRaising FY 2022 revenue guidance range to $71-74 million
MARLBOROUGH, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (Akoya), The Spatial Biology Company®, today announced its financial results for the second quarter ending June 30, 2022.
Akoya delivered another quarter of strong financial performance with record revenue and system placements in the second quarter, said Brian McKelligon, Chief Executive Officer, Akoya Biosciences. This quarter was further highlighted by the announcement of our partnership with Acrivon Therapeutics and the demonstration of our RNA and multi-omics capabilities at AGBT.
...
More
